MSV
RPRX icon

MN Services Vermogensbeheer’s Royalty Pharma RPRX Stock Holding History

MN Services Vermogensbeheer’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-58,600
Closed -$2.81M – 465
2026
Q1 		$2.81M Hold
58,600
– – 0.02% 413
2025
Q4 		$2.26M Sell
58,600
-8,400
-13% -$320K 0.01% 431
2025
Q3 		$2.36M Hold
67,000
– – 0.02% 447
2025
Q2 		$2.41M Buy
+67,000
New +$2.22M 0.02% 449

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MN Services Vermogensbeheer's RPRX Position: Q2 2026 in Review

MN Services Vermogensbeheer sold out of Royalty Pharma (RPRX) in Q2 2026, closing a stake of 58,600 shares — an estimated $2.81M sold.

MN Services Vermogensbeheer first reported a position in RPRX in Q2 2025 and held it in 4 quarters. The position peaked at $2.81M in Q1 2026. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • MN Services Vermogensbeheer reported no remaining Royalty Pharma position as of Q2 2026 after selling out during the quarter.
  • MN Services Vermogensbeheer sold 58,600 Royalty Pharma shares in Q2 2026, an estimated $2.81M.
  • MN Services Vermogensbeheer first reported a position in Royalty Pharma in Q2 2025 and held it in 4 quarters.
  • MN Services Vermogensbeheer's Royalty Pharma position peaked at $2.81M in Q1 2026.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on MN Services Vermogensbeheer's 13F filing for Q2 2026, filed 31 Jul 2026.